Early predictors of cardiac decompensation in experimental volume overload

Molecular and Cellular Biochemistry

Volumn 338, Issue 1-2, 2010, Pages 271-282

  Oliver Dussault, Christelle ^a   Ascah, Alexis ^b   Marcil, Mariannick ^a   Matas, Jimmy ^b   Picard, Sylvie ^a   Pibarot, Philippe ^c   Burelle, Yan ^b   Deschepper, Christian F ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Animal models; Cardiac remodeling; Cardiac risk predictors; Congestive heart failure; Genetic factors; Volume overload cardiopathy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTERIAL STIFFNESS; ARTICLE; CONTROLLED STUDY; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE OVERLOAD; HEART MITOCHONDRION; MALE; MATHEMATICAL ANALYSIS; MORPHOLOGY; MORTALITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGENATION; PREDICTOR VARIABLE; RAT; RAT STRAIN; REOXYGENATION; SPRAGUE DAWLEY RAT; WISTAR KYOTO RAT; ANIMAL; CARDIOMEGALY; COMPLICATION; DEATH, SUDDEN, CARDIAC; DIASTOLE; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART VENTRICLE; HEART VENTRICLE REMODELING; HEART VOLUME; HUMAN; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SURGERY; SURVIVAL RATE;

ANIMALS; CARDIAC VOLUME; CARDIOMEGALY; COLLAGEN; DEATH, SUDDEN, CARDIAC; DIASTOLE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MITOCHONDRIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; POLYMORPHISM, GENETIC; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RISK FACTORS; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

ANIMALIA; FISTULA; RATTUS;

COLLAGEN;

EID: 77951295968     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0361-5     Document Type: Article

References (49)

1. N Frey EN Olson 2003 Cardiac hypertrophy: the good, the bad, and the ugly Annu Rev Physiol 65 45 79 10.1146/annurev.physiol.65.092101.142243 1:CAS:528:DC%2BD3sXjt1Glt74%3D 12524460 (Pubitemid 38249147)
2. DL Mann 2004 Basic mechanisms of left ventricular remodeling: the contribution of wall stress J Card Fail 10 S202 S206 10.1016/j.cardfail.2004.09. 008 1:CAS:528:DC%2BD2MXpsFaisA%3D%3D 15803551
3. BH Lorell BA Carabello 2000 Left ventricular hypertrophy. Pathogenesis, detection and prognosis Circulation 102 470 479 1:STN:280:DC%2BD3czptlKmug%3D%3D 10908222
4. BA Carabello 2008 The current therapy for mitral regurgitation J Am Coll Cardiol 52 319 326 10.1016/j.jacc.2008.02.084 18652937 (Pubitemid 352002859)
5. LH Ling M Enriquez-Sarano JB Seward AJ Tajik HV Schaff KR Bailey RL Frye 1996 Clinical outcome of mitral regurgitation due to flail leaflet N Engl J Med 335 1417 1423 10.1056/NEJM199611073351902 1:STN:280:DyaK2s%2FivF2qtw%3D%3D 8875918 (Pubitemid 26382502)
6. M Enriquez-Sarano JF Avierinos D Messika-Zeitoun D Detaint M Capps V Nkomo C Scott HV Schaff AJ Tajik 2005 Quantitative determinants of the outcome of asymptomatic mitral regurgitation N Engl J Med 352 875 883 10.1056/NEJMoa041451 1:CAS:528:DC%2BD2MXhvFOhtr4%3D 15745978 (Pubitemid 40300296)
7. F Grigioni M Enriquez-Sarano LH Ling KR Bailey JB Seward AJ Tajik RL Frye 1999 Sudden death in mitral regurgitation due to flail leaflet J Am Coll Cardiol 34 2078 2085 10.1016/S0735-1097(99)00474-X 1:STN:280: DC%2BD3c%2FltlCnug%3D%3D 10588227 (Pubitemid 30002668)
8. CM Otto 2003 Timing of surgery in mitral regurgitation Heart 89 100 105 10.1136/heart.89.1.100 12482807
9. Y Liao F Ishikura S Beppu M Asakura S Takashima H Asanuma S Sanada J Kim H Ogita T Kuzuya K Node M Kitakaze M Hori 2002 Echocadiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation Am J Physiol 282 H1703 H1708 1:CAS:528:DC%2BD38XjslWmtrw%3D
10. SM Dolgilevich FM Siri SA Atlas C Eng 2001 Changes in collagenase and collagen gene expression after induction of aortocaval fistula in rats Am J Physiol Heart Circ Physiol 281 H207 H214 1:CAS:528:DC%2BD3MXltVynsr0%3D 11406487
11. GL Brower AL Chancey S Thanigaraj BB Matsubara JS Janicki 2002 Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity Am J Physiol Heart Circ Physiol 283 H518 H525 1:CAS:528:DC%2BD38XmslSiurg%3D 12124196
12. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ (2007) Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49:811-821
13. GL Brower JR Henegar JS Janicki 1996 Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload Am J Physiol 271 H2071 H2078 1:CAS:528:DyaK28XntFyksLc%3D 8945927
14. GL Brower JS Janicki 2001 Contribution of ventricular remodeling to pathogenesis of heart failure in rats Am J Physiol 280 H674 H683 1:CAS:528:DC%2BD3MXjtVWlurw%3D
15. X Wang B Ren S Liu E Sentex PS Tappia NS Dhalla 2003 Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat J Appl Physiol 94 752 763 1:CAS:528:DC%2BD3sXhsFels7w%3D 12531914
16. Matas J, Marcil M, Ascah A, Deschepper CF, Burelle Y. Implication of cyclophilin-D and the mitochondrial permeability transition pore in mitochondrial vulnerability of compensated myocardial hypertrophy. FASEB Journal 22, 751.7. 2008
17. E Souzeau S Belanger S Picard CF Deschepper 2005 Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood Am J Physiol Heart Circ Physiol 289 H715 H721 10.1152/ajpheart.00061. 2005 1:CAS:528:DC%2BD2MXotFaqu7o%3D 15778278 (Pubitemid 41129388)
18. CF Deschepper S Picard G Thibault R Touyz JL Rouleau 2002 Characterization of left ventricular myocardium, isolated cardiomyocytes and blood pressure in WKHA and WKY rats Am J Physiol 82 H149 H155
19. BA Borlaug DA Kass 2006 Mechanisms of diastolic dysfunction in heart failure Trends Cardiovasc Med 16 273 279 10.1016/j.tcm.2006.05.003 17055383 (Pubitemid 44572803)
20. S Watanabe J Shite H Takaoka T Shinke Y Imuro T Ozawa H Otake D Matsumoto D Ogasawara OL Paredes M Yokoyama 2006 Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure Eur Heart J 27 832 838 10.1093/eurheartj/ehi772 1:CAS:528:DC%2BD28XjvFOntLk%3D 16464912
21. GR Norton J Tsotetsi B Trifunovic C Hartford GP Candy AJ Woodiwiss 1997 Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats Circulation 96 1991 1998 1:CAS:528:DyaK2sXmsVChsbw%3D 9323091
22. LM De Stefano LS Matsubara BB Matsubara 2006 Myocardial dysfunction with increased ventricular compliance in volume overload hypertrophy Eur J Heart Fail 8 784 789 10.1016/j.ejheart.2006.02.005 16920023 (Pubitemid 44779408)
23. M Marcil A Ascah J Matas S Belanger CF Deschepper Y Burelle 2006 Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress J Mol Cell Cardiol 41 998 1009 10.1016/j.yjmcc.2006.08.117 1:CAS:528:DC%2BD2sXisFaqtA%3D%3D 17064727 (Pubitemid 44791335)
24. J Liu MR Masurekar DE Vatner GN Jyothirmayi TJ Regan SF Vatner LG Meggs A Malhotra 2003 Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart Am J Physiol Heart Circ Physiol 285 H2587 H2591 1:CAS:528:DC%2BD2cXhsVam 12946933
25. S Brown M Worsfold C Sharp 2001 Microplate assay for the measurement of hydroxyproline in acid-hydrolyzed tissue samples Biotechniques 30 42 48
26. JN Cohn 1995 Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition Circulation 91 2504 2507 1:STN:280: DyaK2M3mt1ahtg%3D%3D 7743609
27. R Jacob RW Gulch 1998 The functional significance of ventricular geometry for the transition from hypertrophy to cardiac failure. Does a critical degree of structural dilatation exist? Basic Res Cardiol 93 423 429 10.1007/s003950050111 1:STN:280:DyaK1M%2FpsFGhsg%3D%3D 9879447 (Pubitemid 29004766)
28. DL Mann MR Bristow 2005 Mechanisms and models in heart failure. The biochemical model and beyond Circulation 111 2837 2849 10.1161/CIRCULATIONAHA. 104.500546 15927992 (Pubitemid 40791557)
29. JS Janicki GL Brower JD Gardner AL Chancey JA Stewart Jr 2004 The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling Heart Fail Rev 9 33 42 10.1023/B:HREV.0000011392.03037.7e 1:CAS:528:DC%2BD2cXisVegtw%3D%3D 14739766 (Pubitemid 38196075)
30. TM Behr X Wang N Aiyar RW Coatney X Li P Koster CE Angermann E Ohlstein GZ Feuerstein J Winaver 2000 Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure Circulation 102 1315 1322 1:CAS:528:DC%2BD3cXntFCgt7c%3D 10982549
31. AL Chancey GL Brower JS Janicki 2002 Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function Am J Physiol Heart Circ Physiol 282 H2152 H2158 1:CAS:528:DC%2BD38Xks12nsbs%3D 12003823
32. RS Vasan MG Larson EJ Benjamin JC Evans D Levy 1997 Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1350 1355 10.1056/NEJM199705083361903 1:STN:280:DyaK2s3mtlCgtA%3D%3D 9134875 (Pubitemid 27208618)
33. KT Weber Y Sun SC Tyagi JP Cleutjens 1994 Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms J Mol Cell Cardiol 26 279 292 10.1006/jmcc.1994.1036 1:CAS:528:DyaK2cXis1Kns7g%3D 8028011 (Pubitemid 24199288)
34. T Namba H Tsutsui H Tagawa M Takahashi K Saito T Kozai M Usui K Imanaka-Yoshida T Imaizumi A Takeshita 1997 Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy Circulation 95 2448 2454 1:CAS:528:DyaK2sXjslKhtbo%3D 9170409
35. AJ Woodiwiss OJ Tsotetsi S Sprott EJ Lancaster T Mela ES Chung TE Meyer GR Norton 2001 Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction Circulation 103 155 160 1:CAS:528:DC%2BD3MXhtFelt7Y%3D 11136701
36. DS Iimoto JW Covell E Harper 1988 Increase in cross-linking of type I and type III collagens associated with volume-overload hypertrophy Circ Res 63 399 408 1:CAS:528:DyaL1cXlt1Kktro%3D 2969308
37. JB Caulfield P Norton RD Weaver 1992 Cardiac dilatation associated with collagen alterations Mol Cell Biochem 118 171 179 10.1007/BF00299396 1:CAS:528:DyaK3sXhsVCgs70%3D 1293511
38. FG Spinale ML Coker BR Bond JL Zellner 2000 Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target Cardiovasc Res 46 225 238 10.1016/S0008-6363(99)00431-9 1:CAS:528:DC%2BD3cXisFGru7o%3D 10773226 (Pubitemid 30204594)
39. JF Avierinos D Detaint D Messika-Zeitoun D Mohty M Enriquez-Sarano 2008 Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community Am J Cardiol 101 662 667 10.1016/j.amjcard.2007.10.029 18308017 (Pubitemid 351625094)
40. M Enriquez-Sarano AJ Basmadjian A Rossi KR Bailey JB Seward AJ Tajik 1999 Progression of mitral regurgitation: a prospective Doppler echocardiographic study J Am Coll Cardiol 34 1137 1144 10.1016/S0735-1097(99)00313-7 1:STN:280:DyaK1MvkvFWisQ%3D%3D 10520803 (Pubitemid 29500551)
41. KL Svenson SR Von PA Magnani HR Suetin B Paigen JK Naggert R Li GA Churchill LL Peters 2007 Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations J Appl Physiol 102 2369 2378 10.1152/japplphysiol.01077.2006 1:CAS:528: DC%2BD2sXnsVKms70%3D 17317875 (Pubitemid 47080772)
42. R Lee TH Marwick 2007 Assessment of subclinical left ventricular dysfunction in asymptomatic mitral regurgitation Eur J Echocardiogr 8 175 184 10.1016/j.euje.2006.11.002 17240198 (Pubitemid 46657227)
43. RO Bonow BA Carabello C Kanu AC de Leon Jr DP Faxon MD Freed WH Gaasch BW Lytle RA Nishimura PT O'Gara RA O'Rourke CM Otto PM Shah JS Shanewise Smith SC Jr AK Jacobs CD Adams JL Anderson EM Antman DP Faxon V Fuster JL Halperin LF Hiratzka SA Hunt BW Lytle R Nishimura RL Page B Riegel 2006 ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 e84 231 10.1161/CIRCULATIONAHA.106.176857 16880336 (Pubitemid 44268973)
44. T Edvardsen H Skulstad S Aakhus S Urheim H Ihlen 2001 Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography J Am Coll Cardiol 37 726 730 10.1016/S0735-1097(00)01160-8 1:STN:280:DC%2BD3MnjslagsQ%3D%3D 11693743 (Pubitemid 32202436)
45. R Lee L Hanekom TH Marwick R Leano S Wahi 2004 Prediction of subclinical left ventricular dysfunction with strain rate imaging in patients with asymptomatic severe mitral regurgitation Am J Cardiol 94 1333 1337 10.1016/j.amjcard.2004.07.129 15541262 (Pubitemid 39469965)
46. TH Marwick RL Leano J Brown JP Sun R Hoffman P Lysyanski M Becker JD Thomas 2009 Myocardial strain measurements with 2-dimensional speckle-tracking echocardiography J Am Coll Cardiol Img 2 80 84
47. J Layland IS Young JD Altringham 1995 The length dependence of work production in rat papillary muscles in vitro J Exp Biol 198 2491 2499 1:STN:280:DyaK287gs1Wmtg%3D%3D 8576681
48. JC Kentish GJ Stienen 1994 Differential effects of length on maximum force production and myofibrillar ATPase activity in rat skinned cardiac muscle J Physiol 475 175 184 1:CAS:528:DyaK2cXivFGjsrg%3D 8189390
49. PS Petkova-Kirova E Gursoy H Mehdi CF McTiernan B London G Salama 2006 Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha Am J Physiol Heart Circ Physiol 290 H2098 H2107 10.1152/ajpheart.00097.2005 1:CAS:528: DC%2BD28XkvFSmt7s%3D 16339842